{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T18:46:59Z","timestamp":1789152419232,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"am","delay-in-days":274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.bbagen.2021.129933","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T12:44:23Z","timestamp":1621601063000},"page":"129933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Botulinum neurotoxin inhibitor binding dynamics and kinetics relevant for drug design"],"prefix":"10.1016","volume":"1865","author":[{"given":"Kruti B.","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Kononova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuowei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeri","family":"Barsegov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virinder S.","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bal Ram","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbagen.2021.129933_bb0005","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bbagen.2021.129933_bb0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/00000441-200206000-00005","article-title":"Microbiological, biological, and chemical weapons of warfare and terrorism","volume":"323","author":"Greenfield","year":"2002","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.bbagen.2021.129933_bb0015","doi-asserted-by":"crossref","first-page":"9984","DOI":"10.1073\/pnas.0408526102","article-title":"Analyzing a bioterror attack on the food supply: the case of botulinum toxin in milk","volume":"102","author":"Wein","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2021.129933_bb0020","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1124\/pr.116.012658","article-title":"Botulinum neurotoxins: biology, pharmacology, and toxicology","volume":"69","author":"Pirazzini","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bbagen.2021.129933_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF03033925","article-title":"Botulinum neurotoxin structure, engineering, and novel cellular trafficking and targeting","volume":"9","author":"Singh","year":"2006","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.bbagen.2021.129933_bb0030","first-page":"135","article-title":"Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism","volume":"5","author":"Greenfield","year":"2004","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.bbagen.2021.129933_bb0035","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/(SICI)1097-4598(199806)21:6<701::AID-MUS1>3.0.CO;2-B","article-title":"Clinical spectrum of botulism","volume":"21","author":"Cherington","year":"1998","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.bbagen.2021.129933_bb0040","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.toxicon.2013.02.014","article-title":"The life history of a botulinum toxin molecule","volume":"68","author":"Simpson","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2021.129933_bb0045","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1128\/mr.44.3.419-448.1980","article-title":"Clostridium botulinum neurotoxin","volume":"44","author":"Sugiyama","year":"1980","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.bbagen.2021.129933_bb0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbagen.2021.129933_bb0055","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/2338","article-title":"Crystal structure of botulinum neurotoxin type A and implications for toxicity","volume":"5","author":"Lacy","year":"1998","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.bbagen.2021.129933_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228715","article-title":"Special delivery: potential mechanisms of Botulinum neurotoxin uptake and trafficking within motor nerve terminals","volume":"21","author":"Winner","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbagen.2021.129933_bb0065","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.toxicon.2009.11.017","article-title":"The identification and biochemical characterization of drug-like compounds that inhibit botulinum neurotoxin serotype A endopeptidase activity","volume":"55","author":"Cai","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.bbagen.2021.129933_bb0070","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1021\/jm061446e","article-title":"A refined pharmacophore identifies potent 4-amino-7-chloroquinoline-based inhibitors of the botulinum neurotoxin serotype A metalloprotease","volume":"50","author":"Burnett","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0075","doi-asserted-by":"crossref","first-page":"5004","DOI":"10.1074\/jbc.M608166200","article-title":"Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons","volume":"282","author":"Burnett","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0080","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/17460441.2014.884066","article-title":"Current strategies for designing antidotes against botulinum neurotoxins","volume":"9","author":"Patel","year":"2014","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.bbagen.2021.129933_bb0085","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/0041-0101(94)00188-E","article-title":"A study of zinc-dependent metalloendopeptidase inhibitors as pharmacological antagonists in botulinum neurotoxin poisoning","volume":"33","author":"Deshpande","year":"1995","journal-title":"Toxicon"},{"issue":"Suppl. 1","key":"10.1016\/j.bbagen.2021.129933_bb0090","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1002\/(SICI)1099-1263(199912)19:1+<S5::AID-JAT606>3.0.CO;2-M","article-title":"Evaluation of phosphoramidon and three synthetic phosphonates for inhibition of botulinum neurotoxin B catalytic activity","volume":"19","author":"Adler","year":"1999","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.bbagen.2021.129933_bb0095","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/ml100074s","article-title":"Identification of a natural product antagonist against the Botulinum neurotoxin light chain protease","volume":"1","author":"Eubanks","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbagen.2021.129933_bb0100","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.6b01393","article-title":"Newly designed Quinolinol inhibitors mitigate the effects of Botulinum neurotoxin a in enzymatic, cell-based, and ex vivo assays","author":"Bremer","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0105","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.00141-09","article-title":"Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A","volume":"53","author":"Roxas-Duncan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bbagen.2021.129933_bb0110","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0611213104","article-title":"An in vitro and in vivo disconnect uncovered through high-throughput identification of botulinum neurotoxin A antagonists","volume":"104","author":"Eubanks","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2021.129933_bb0115","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1016\/j.str.2008.07.011","article-title":"A potent peptidomimetic inhibitor of botulinum neurotoxin serotype A has a very different conformation than SNAP-25 substrate","volume":"16","author":"Zuniga","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.bbagen.2021.129933_bb0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1381612053382115","article-title":"Recent developments in the design of specific Matrix Metalloproteinase inhibitors aided by structural and computational studies","volume":"11","author":"Rao","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbagen.2021.129933_bb0125","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.2174\/092986705774454706","article-title":"Non-hydroxamate histone deacetylase inhibitors","volume":"12","author":"Suzuki","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0130","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.01280-18","article-title":"Natural compounds and their analogues as potent antidotes against the Most poisonous bacterial toxin","author":"Patel","year":"2018","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.bbagen.2021.129933_bb0135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/prep.1999.1138","article-title":"High-level expression, purification, and characterization of recombinant type a botulinum neurotoxin light chain","volume":"17","author":"Li","year":"1999","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.bbagen.2021.129933_bb0140","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bbrc.2010.05.006","article-title":"In vitro selection of RNA aptamers that inhibit the activity of type A botulinum neurotoxin","volume":"396","author":"Chang","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbagen.2021.129933_bb0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0968-0004(90)90295-M","article-title":"Using linear and non-linear regression to fit biochemical data","volume":"15","author":"Leatherbarrow","year":"1990","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbagen.2021.129933_bb0150","series-title":"Principles of Fluorescence Spectroscopy","author":"Lakowicz","year":"2006"},{"issue":"33\u20138","key":"10.1016\/j.bbagen.2021.129933_bb0155","first-page":"27","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J. Mol. Graph."},{"key":"10.1016\/j.bbagen.2021.129933_bb0160","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program","volume":"30","author":"Brooks","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0165","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/prot.10001","article-title":"Evaluation of a fast implicit solvent model for molecular dynamics simulations","volume":"46","author":"Ferrara","year":"2002","journal-title":"Proteins"},{"key":"10.1016\/j.bbagen.2021.129933_bb0170","doi-asserted-by":"crossref","first-page":"20396","DOI":"10.1021\/ja3076428","article-title":"Mechanical transition from alpha-helical coiled coils to beta-sheets in fibrin(ogen)","volume":"134","author":"Zhmurov","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbagen.2021.129933_bb0175","series-title":"Amber 2018","author":"IYB-S","year":"2018"},{"key":"10.1016\/j.bbagen.2021.129933_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0065-3233(03)66002-X","article-title":"Force fields for protein simulations","volume":"66","author":"Ponder","year":"2003","journal-title":"Adv. Protein Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0190","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/ct200909j","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born","volume":"8","author":"Gotz","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2021.129933_bb0195","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/ct400314y","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 2. Explicit solvent particle mesh Ewald","volume":"9","author":"Salomon-Ferrer","year":"2013","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.bbagen.2021.129933_bb0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF00223515","article-title":"Structure of heavy and light chain subunits of type A botulinum neurotoxin analyzed by circular dichroism and fluorescence measurements","volume":"85","author":"Singh","year":"1989","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0205","doi-asserted-by":"crossref","first-page":"6466","DOI":"10.1021\/bi992729u","article-title":"Spectroscopic analysis of pH-induced changes in the molecular features of type A botulinum neurotoxin light chain","volume":"39","author":"Li","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2021.129933_bb0210","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1021\/j100809a020","article-title":"Oxygen quenching of fluorescence in solution: an experimental study of the diffusion process","volume":"66","author":"Ware","year":"1962","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0215","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.abb.2017.01.006","article-title":"Mechanism of inhibition of botulinum neurotoxin type A light chain by two quinolinol compounds","volume":"618","author":"Minnow","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2021.129933_bb0220","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.abb.2009.09.008","article-title":"Quinolinol and peptide inhibitors of zinc protease in botulinum neurotoxin a: effects of zinc ion and peptides on inhibition","volume":"491","author":"Lai","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bbagen.2021.129933_bb0225","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nature03123","article-title":"Substrate recognition strategy for botulinum neurotoxin serotype A","volume":"432","author":"Breidenbach","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbagen.2021.129933_bb0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.molmed.2005.06.012","article-title":"New insights into clostridial neurotoxin-SNARE interactions","volume":"11","author":"Breidenbach","year":"2005","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbagen.2021.129933_bb0235","series-title":"Analysis of molecular topography and functional activities to decode unique features of botulinum neurotoxin endopeptidase. Ph. D","author":"Felturp","year":"2016"},{"key":"10.1016\/j.bbagen.2021.129933_bb0240","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1080\/07391102.2013.791878","article-title":"Botulinum neurotoxin: unique folding of enzyme domain of the most-poisonous poison","volume":"32","author":"Kumar","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bbagen.2021.129933_bb0245","doi-asserted-by":"crossref","first-page":"8575","DOI":"10.1073\/pnas.1802576115","article-title":"Regulatory element in fibrin triggers tension-activated transition from catch to slip bonds","volume":"115","author":"Litvinov","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbagen.2021.129933_bb0250","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1021\/acs.biochem.6b01113","article-title":"Mechanistic basis for the binding of RGD- and AGDV-peptides to the platelet integrin alphaIIbbeta3","volume":"56","author":"Kononova","year":"2017","journal-title":"Biochemistry"},{"key":"10.1016\/j.bbagen.2021.129933_bb0255","doi-asserted-by":"crossref","first-page":"22681","DOI":"10.1074\/jbc.M113.472365","article-title":"Molecular mechanisms, thermodynamics, and dissociation kinetics of knob-hole interactions in fibrin","volume":"288","author":"Kononova","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0260","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10822-014-9758-7","article-title":"Structural insight into exosite binding and discovery of novel exosite inhibitors of botulinum neurotoxin serotype A through in silico screening","volume":"28","author":"Hu","year":"2014","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.bbagen.2021.129933_bb0265","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1107\/S0907444912003551","article-title":"Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling","volume":"68","author":"Kumar","year":"2012","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.bbagen.2021.129933_bb0270","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bmc.2004.10.026","article-title":"Conformational sampling of the botulinum neurotoxin serotype A light chain: implications for inhibitor binding","volume":"13","author":"Burnett","year":"2005","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bbagen.2021.129933_bb0275","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/bip.22682","article-title":"Understanding peptide competitive inhibition of botulinum neurotoxin a binding to SV2 protein via molecular dynamics simulations","volume":"103","author":"Chang","year":"2015","journal-title":"Biopolymers"}],"container-title":["Biochimica et Biophysica Acta (BBA) - General Subjects"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441652100091X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030441652100091X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:09:09Z","timestamp":1759637349000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030441652100091X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":55,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S030441652100091X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbagen.2021.129933","relation":{},"ISSN":["0304-4165"],"issn-type":[{"value":"0304-4165","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Botulinum neurotoxin inhibitor binding dynamics and kinetics relevant for drug design","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - General Subjects","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbagen.2021.129933","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"129933"}}